v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

THE EFFECTIVENESS OF TOPICAL ZINC OXIDE OINTMENT IN THE TREATMENT OF CUTANEOUS PATHOLOGICAL WARTS

AUTHORS:

Dr. Imtiaz Ahmad, Dr. Zaffar Iqbal, Dr. Niaz Ahmad

ABSTRACT:

Objective: The aim of our study was to find out the effectiveness of Topical Zinc Oxide 20 % Ointment in the treatment of cutaneous warts on hands and feet. Study Design: A prospective descriptive study. Place and Duration: This study was conducted at the Outpatient Department (OPDs) of Dermatology, Nishtar Hospital, Multan for the duration of three months starting from June, 2020 to September, 2020. Methodology: In our study we enrolled 255 and instructed patients to apply topical 20% Zinc Oxide Ointment twice a day. The enrolled patients follow the instruction to applying topical 20% Zinc Oxide Ointment for 3 months or till complete the treatment. We calculate the percentage decrease from baseline as: Total number of warts decrease from baseline at 3 Months multiply by 100, divided by total number of warts at baseline. SPSS v. 20 was used for the analysis of data. Results: In our present study we enrolled 255 patients in which according to gender 82 patients (32.2%) out of 255 were male and 173 patients (67.8%) out of 255 were female. 17.55±4.48 years was mean age of patients. At the end of 3 months of treatment we observed complete cure in 127 patients (49.8%), moderate response was saw in 41 patients (16.1%), no response was saw in 35 patients (13.7%), mild response was saw in 10 patients (3.9%), significant response was saw in 32 patients (12.6%) and the excellent response was saw in 10 patients (3.9%). Conclusion: At the end of study, we conclude that safe and effective treatment for warts of feet and hands may be Topical Zinc Oxide (20%) Ointment. Keywords: Ointment, Outcome, Cutaneous Warts, Zinc Oxide

FULL TEXT

<
Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.